Case number 1:18-cv-01775
Insys Therapeutics, Inc. et al v. Teva Pharmaceuticals USA Inc. et al > Documents
| Date Field | Doc. No. | Description (Pages) |
|---|---|---|
| Nov 9, 2022 | 12 | [SEALED] SO ORDERED, re (107 in 1:17-cv-01303-CFC) Stipulation of Dismissal, filed by Teva Pharmaceuticals USA, Inc. CASE CLOSED. Signed by Judge Colm F. Connolly on 11/9/2022.This order has been emailed to local counsel. Associated Cases: 1:17-cv-01303-CFC, 1:18-cv-00414-CFC, 1:18-cv-01308-CFC, 1:18-cv-01775-CFC(kmd) (Entered: 11/09/2022) (0) |
| Jul 15, 2019 | N/A | Case Stayed (0) Docket Text: Case Stayed per the entry of the Stay Order in Lead Case No. 17-1303-CFC. (nmf) |
| Feb 19, 2019 | N/A | CORRECTING ENTRY: (0) Docket Text: CORRECTING ENTRY: The Oral Order (DI 58 in 17-1303; DI 24 in 18-414; DI 16 in 18-1308; and DI 12 in 18-1775) resetting the time for the teleconference on 2/26/19 to 11:00 am was docketed in error and was removed from the docket. The teleconference was rescheduled to 4/23/19 at 10:00 a.m. Associated Cases: 1:17-cv-01303-CFC, 1:18-cv-00414-CFC, 1:18-cv-01308-CFC, 1:18-cv-01775-CFC(cak) |
| Jan 7, 2019 | N/A | Create Case Association (0) Docket Text: Case associated with lead case: Create association to 1:17-cv-01303-CFC. (fms) |
| Jan 7, 2019 | 11 | SO ORDERED (6) Docket Text: SO ORDERED, re (10 in 1:18-cv-01775-CFC, 49 in 1:17-cv-01303-CFC) Stipulation and Proposed Order to Consolidate and Dismiss Teva Pharmaceutical Industries, Ltd. filed by Insys Development Company, Inc., Insys Therapeutics, Inc. Party Teva Pharmaceutical Industries Ltd. terminated from 18-1775 CFC. The parties agree to consolidate the 1775 action into the consolidated 1303 action for all purposes and that ALL PAPERS WILL BE FILED IN C.A. No. 17-1303. See Stipulation for further details. Signed by Judge Colm F. Connolly on 1/7/2019. Associated Cases: 1:17-cv-01303-CFC, 1:18-cv-01775-CFC(fms) |
| Jan 4, 2019 | 10 | Proposed Order (6) Docket Text: Joint PROPOSED ORDER Stipulation and [Proposed] Order to Consolidate and Dismiss Teva Pharmaceutical Industries, Ltd. by Insys Development Company, Inc., Insys Therapeutics, Inc.. (Ying, Jennifer) |
| Jan 3, 2019 | N/A | Remark (0) Docket Text: Remark: The 1/7/2019 at 02:00 PM Scheduling Conference is cancelled per counsel. (nmf) |
| Dec 11, 2018 | N/A | Add Attorneys Pro Hac Vice (0) Docket Text: Pro Hac Vice Attorney Deirdre M. Wells,J.C. Rozendaal,Paul A. Ainsworth for Teva Pharmaceutical Industries Ltd., Teva Pharmaceuticals USA Inc. added for electronic noticing. Pursuant to Local Rule 83.5 (d)., Delaware counsel shall be the registered users of CM/ECF and shall be required to file all papers. (crb) |
| Dec 11, 2018 | 9 | Order Setting Scheduling Conference (1) Docket Text: Order Setting Scheduling Conference: A Scheduling Conference is set for 1/7/2019 at 02:00 PM in Chambers before Judge Colm F. Connolly. Signed by Judge Colm F. Connolly on 12/11/2018. (nmf) |
| Dec 10, 2018 | N/A | SO ORDERED (0) Docket Text: SO ORDERED, re [8] MOTION for Pro Hac Vice Appearance of Attorney J.C. Rozendaal, Paul A. Ainsworth and Deirdre Wells filed by Teva Pharmaceutical Industries Ltd., Teva Pharmaceuticals USA Inc. Signed by Judge Colm F. Connolly on 12/10/2018. (fms) |
| Dec 10, 2018 | 8 | Motion for Leave to Appear Pro Hac Vice (5) Docket Text: MOTION for Pro Hac Vice Appearance of Attorney J.C. Rozendaal, Paul A. Ainsworth and Deirdre Wells - filed by Teva Pharmaceutical Industries Ltd., Teva Pharmaceuticals USA Inc.. (Hoeschen, Nathan) |
| Dec 6, 2018 | 7 | Answer to Counterclaim (5) Docket Text: ANSWER to [6] Answer to Complaint, Counterclaim by Insys Development Company, Inc., Insys Therapeutics, Inc..(Ying, Jennifer) |
| Nov 19, 2018 | 6 | Answer to Complaint (10) Docket Text: ANSWER to [1] Complaint, , COUNTERCLAIM against All Plaintiffs by Teva Pharmaceutical Industries Ltd., Teva Pharmaceuticals USA Inc..(Fry, David) |
| Nov 14, 2018 | N/A | Case Assigned/Reassigned (0) Docket Text: Case Assigned to Judge Colm F. Connolly. Please include the initials of the Judge (CFC) after the case number on all documents filed. (rjb) |
| Nov 9, 2018 | N/A | Summons Issued (0) Docket Text: Summons Issued with Magistrate Consent Notice attached as to Teva Pharmaceutical Industries Ltd. on 11/9/2018; Teva Pharmaceuticals USA Inc. on 11/9/2018. Requesting party or attorney should pick up issued summons at the Help Desk, Room 4209, or call 302-573-6170 and ask the Clerk to mail the summons to them. (ceg) |
| Nov 9, 2018 | 1 | Main Document (10) Docket Text: COMPLAINT FOR PATENT INFRINGEMENT filed against Teva Pharmaceutical Industries Ltd., Teva Pharmaceuticals USA Inc. - Magistrate Consent Notice to Pltf. ( Filing fee $ 400, receipt number 0311-2501341.) - filed by Insys Therapeutics, Inc., Insys Development Company, Inc. (Attachments: # (1) Exhibit A, # (2) Civil Cover Sheet)(ceg) |
| Nov 9, 2018 | 1 | Exhibit A (41) |
| Nov 9, 2018 | 1 | Civil Cover Sheet (1) |
| Nov 9, 2018 | 2 | Magistrate Consent Forms (3) Docket Text: Notice, Consent and Referral forms re: U.S. Magistrate Judge jurisdiction. (ceg) |
| Nov 9, 2018 | 3 | ANDA Form (1) Docket Text: Supplemental information for patent cases involving an Abbreviated New Drug Application (ANDA) - Date Patentee(s) Received Notice: 9/25/2018. Date of Expiration of Patent: 1/25/2027.Thirty Month Stay Deadline: 7/31/2020. (ceg) |
| Nov 9, 2018 | 4 | Patent/Trademark Report to Commissioner (1) Docket Text: Report to the Commissioner of Patents and Trademarks for Patent/Trademark Number(s) 10,016,403 B2. (ceg) (Main Document 4 replaced on 11/16/2018) (ceg). |
| Nov 9, 2018 | 5 | Disclosure Statement (2) Docket Text: Disclosure Statement pursuant to Rule 7.1: identifying Corporate Parent Insys Therapeutics, Inc. for Insys Development Company, Inc. filed by Insys Development Company, Inc., Insys Therapeutics, Inc. (ceg) |
| Nov 9, 2018 | 1 | Complaint* (1) |
